[go: up one dir, main page]

EA200801978A1 - Способ получения и применения фармакологически активного n-карбамоилметил-4(r)-фенил-2-пирролидинона - Google Patents

Способ получения и применения фармакологически активного n-карбамоилметил-4(r)-фенил-2-пирролидинона

Info

Publication number
EA200801978A1
EA200801978A1 EA200801978A EA200801978A EA200801978A1 EA 200801978 A1 EA200801978 A1 EA 200801978A1 EA 200801978 A EA200801978 A EA 200801978A EA 200801978 A EA200801978 A EA 200801978A EA 200801978 A1 EA200801978 A1 EA 200801978A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pyrrolidinone
phenyl
carbamoilmethil
production
application
Prior art date
Application number
EA200801978A
Other languages
English (en)
Other versions
EA014668B1 (ru
Inventor
Григорий Вейнберг
Максим Ворона
Лига Звейниеце
Александрс Чернобровыйс
Иварс Калвиньш
Лигита Кариня
Майя Дамброва
Original Assignee
Акционерное Общество "Олайнфарм"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Акционерное Общество "Олайнфарм" filed Critical Акционерное Общество "Олайнфарм"
Publication of EA200801978A1 publication Critical patent/EA200801978A1/ru
Publication of EA014668B1 publication Critical patent/EA014668B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Изобретение относится к способу получения фармакологически активного R-энантиомера N-карбамоилметил-4-фенил-2-пирролидинона (R-карфедона). Способ его получения включает N-алкилирование 4(R)-фенил-2-пирролидинона этиловым эфиром бромуксусной кислоты в присутствии сильного основания, с последующей обработкой промежуточного N-алкоксикарбонилметил-4(R)-фенил-2-пирролидинона аммиаком.
EA200801978A 2006-03-16 2007-03-15 Способ получения и применения фармакологически активного n-карбамоилметил-4(r)-фенил-2-пирролидинона EA014668B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LVP-06-45A LV13630B (en) 2006-03-16 2006-03-16 Method of preparation and use of pharmaceutically active n-carbamoylmethyl-4(r)-phenyl-2-pyrrolidinone
PCT/EP2007/052424 WO2007104780A2 (en) 2006-03-16 2007-03-15 N- carbamoylmethyl- 4- (r) -phenyl-2-pyrr0lidin0ne, method of its preparation and pharmaceutical use

Publications (2)

Publication Number Publication Date
EA200801978A1 true EA200801978A1 (ru) 2009-04-28
EA014668B1 EA014668B1 (ru) 2010-12-30

Family

ID=38461010

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200801978A EA014668B1 (ru) 2006-03-16 2007-03-15 Способ получения и применения фармакологически активного n-карбамоилметил-4(r)-фенил-2-пирролидинона

Country Status (21)

Country Link
US (2) US9102615B2 (ru)
EP (1) EP2013166B1 (ru)
CN (1) CN101448786A (ru)
AT (1) ATE460396T1 (ru)
CA (1) CA2647206C (ru)
CY (1) CY1110170T1 (ru)
DE (1) DE602007005244D1 (ru)
DK (1) DK2013166T3 (ru)
EA (1) EA014668B1 (ru)
EE (1) EE05536B1 (ru)
ES (1) ES2342024T3 (ru)
GE (1) GEP20104915B (ru)
HR (1) HRP20090524C1 (ru)
LT (1) LT5589B (ru)
LV (1) LV13630B (ru)
ME (1) ME01192B (ru)
PL (1) PL2013166T3 (ru)
PT (1) PT2013166E (ru)
SI (1) SI2013166T1 (ru)
UA (1) UA96440C2 (ru)
WO (1) WO2007104780A2 (ru)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2392915C1 (ru) * 2009-04-14 2010-06-27 Федеральное государственное учреждение "Новокузнецкий научно-практический центр медико-социальной экспертизы и реабилитации инвалидов Федерального агентства по здравоохранению и социальному развитию" (ФГУ ННПЦ МСЭ и РИ Росздрава) Способ формирования двигательных функций у инвалидов с позвоночно-спинно-мозговой травмой
LV14346B (lv) * 2009-11-05 2011-07-20 Grindeks, A/S 2-(4-Fenil-5-metil-2-oksopirolidin-1-il)-acetamīda 4R,5S-enantiomērs ar nootropo aktivitāti
RU2437659C1 (ru) * 2010-11-12 2011-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный педагогический университет им. А.И. Герцена" (РГПУ им. А.И. Герцена) Средство, обладающее антидепрессивным, анксиолитическим и ноотропным действием
WO2012123358A1 (en) * 2011-03-11 2012-09-20 Grindeks 4r,5r-enantiomer of 2-(5-methyl-2-oxo-4-phenyl-pyrrolidin-1-yl)-acetamide with nootropic activity
RU2480214C1 (ru) 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов
DK3517541T3 (da) 2012-05-08 2020-09-07 Nicox Ophthalmics Inc Polymorf form af fluticasonpropionat
TW201408293A (zh) 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa (r)-苯基披喇瑟盪於治療疾病相關疲勞之用途
TW201408294A (zh) 2012-07-05 2014-03-01 Merz Pharma Gmbh & Co Kgaa (r)-苯基披喇瑟盪於治療帕金森氏症之用除
LV15003B (lv) * 2013-10-22 2015-08-20 Latvijas Organiskās Sintēzes Institūts Farmaceitiska kompozīcija ķermeņa masas pieauguma kontrolei
LV15015B (lv) 2013-12-13 2015-12-20 Olainfarm, A/S 3-karboksi-4-(R)-fenilpirolidin-2-ona sāls un tā pielietošana
LV15016B (lv) * 2013-12-18 2016-01-20 Olainfarm, A/S N-karbamoilmetil-4(R)-fenil-2-pirolidinona polimorfās formas
EP2891491A1 (en) 2014-01-03 2015-07-08 Merz Pharma GmbH & Co. KGaA Use of (r)-phenylpiracetam for the treatment of sleep disorders
LV15072B (lv) 2014-05-14 2016-09-20 Olainfarm, A/S Farmaceitiska kompozīcija izmantošanai patoloģiska stāvokļa, kam raksturīga paaugstināta iNOS gēna ekspresija, profilaksei un ārstēšanai
EP3127539A1 (en) * 2015-08-03 2017-02-08 Latvian Institute Of Organic Synthesis Use of 2-(5s-methyl-2-oxo-4r-phenyl-pyrrolidin-1-yl)-acetamide in the treatment of seizures
EP4582412A1 (en) * 2022-08-31 2025-07-09 Korea University Research and Business Foundation Chiral gamma lactam derivative or pharmaceutically acceptable salt thereof, and preparation method therefor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
RU2232578C1 (ru) * 2003-04-10 2004-07-20 Ахапкина Валентина Ивановна Вещество, обладающее антидепрессивной активностью
RU2289404C1 (ru) * 2005-04-06 2006-12-20 ГОУ ВПО "Московский государственный медико-стоматологический университет Министерства здравоохранения РФ" Способ премедикации у пациентов со средним уровнем психоэмоционального напряжения при амбулаторных стоматологических вмешательствах

Also Published As

Publication number Publication date
SI2013166T1 (sl) 2010-07-30
ME01192B (me) 2012-12-20
GEP20104915B (en) 2010-03-10
LT2008075A (en) 2009-06-25
ATE460396T1 (de) 2010-03-15
CA2647206C (en) 2011-09-27
EP2013166B1 (en) 2010-03-10
CN101448786A (zh) 2009-06-03
CA2647206A1 (en) 2007-09-20
WO2007104780A3 (en) 2007-11-29
US20100022784A1 (en) 2010-01-28
PT2013166E (pt) 2010-06-09
PL2013166T3 (pl) 2010-08-31
EP2013166A2 (en) 2009-01-14
LV13630B (en) 2007-12-20
DK2013166T3 (da) 2010-07-05
EE200800063A (et) 2008-12-15
EA014668B1 (ru) 2010-12-30
US9382203B2 (en) 2016-07-05
CY1110170T1 (el) 2015-01-14
WO2007104780A2 (en) 2007-09-20
HRP20090524C1 (hr) 2017-03-10
US20150216846A1 (en) 2015-08-06
DE602007005244D1 (de) 2010-04-22
LT5589B (lt) 2009-08-25
UA96440C2 (ru) 2011-11-10
HRP20090524A2 (hr) 2009-12-31
US9102615B2 (en) 2015-08-11
HRPK20090524B3 (hr) 2012-12-31
EE05536B1 (et) 2012-04-16
ES2342024T3 (es) 2010-06-30

Similar Documents

Publication Publication Date Title
EA200801978A1 (ru) Способ получения и применения фармакологически активного n-карбамоилметил-4(r)-фенил-2-пирролидинона
EA200802203A1 (ru) Дикетопиперазиновые и пиперидиновые производные в качестве противовирусных агентов
MY154909A (en) Novel thiophene derivatives
EA200800147A1 (ru) Способ получения олмесартан медоксомила
EA200870461A1 (ru) Производные лактама циклогексилимидазола в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы 1
TW200700406A (en) Novel thiophene derivatives
UY27777A1 (es) Inhibidores de metaloproteinasa de heteroariloxi-aril-espiro-pirimidina-2,4,6-triona n-sustituida
NO20083726L (no) Spiroindolinon derivater
TW200716591A (en) Novel thiophene derivatives
NO20083630L (no) Nye pyridinderivater
TW200708511A (en) Novel thiophene derivatives
NZ596093A (en) High affinity human antibodies to human il-4 receptor
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
TW200716552A (en) Novel thiophene derivatives
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
MA32544B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
MA32568B1 (fr) Formulations pharmaceutiques contenant des ligands de recepteur de dopamine
MY149028A (en) Nalmefene hydrochloride dihydrate
TW200738670A (en) Novel thiophene derivatives
GEP20146154B (en) Alkaloid aminoester derivatives and medicinal compositions thereof
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
EA200970192A1 (ru) Производные 5,6-бисарил-2-пиридин-карбоксамида, их получение и их применение в терапии в качестве антагонистов рецепторов уротензина ii
MA33915B1 (fr) Nouveaux derives d' (heterocycle-piperidine condensee)-(piperazinyl)-1-alcanone ou d' (heterocycle-pyrrolidine condensee)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
EA200700400A1 (ru) Производные n-(1h-индолил)-1н-индол-2-карбоксамидов, их получение и их применение в терапии

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU